Company / Interest Expense per Share
Cytokinetics Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$379.50
FY2025
5-year range
$0.19 / $379.50
FY2021-FY2025
Trend
+102209.0%
vs FY2024
Sector context
#2 of 43
Health Care
What the data says
Interest Expense per Share changed +102209% YoY in FY2025, a notable deviation from the 9-year average annual change of +11382%.
Based on SEC 10-K filings.
379.50 in FY2025 with a 5-year CAGR of +342.1%. Ranks 2nd among 43 companies in Health Care.
Increased from $0.30 to $379.50 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +342.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 43This company $379.50 Sector average $18.61
▼
+1938.8% above sector average
Key checks
Key Insights
- Cytokinetics's interest expense per share has grown for 4 consecutive years.
- In FY2025, interest expense per share increased 102209.0% year-over-year.
- Ranks #2 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $379.50 | +102209.0% |
| FY2024 | $0.37 | +24.3% |
| FY2023 | $0.30 | +30.4% |
| FY2022 | $0.23 | +18.1% |
| FY2021 | $0.19 | -13.8% |
| FY2020 | $0.22 | +100.8% |
| FY2019 | $0.11 | +61.3% |
| FY2018 | $0.07 | +24.2% |
| FY2017 | $0.06 | -15.8% |
| FY2016 | $0.07 | +880.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026